Salmi A
Recenti Prog Med. 1989 Sep;80(9):466-7.
The authors discuss percutaneous alcohol injection as elective therapy for small hepatocellular carcinoma (less than 5 cm) in liver cirrhosis. Thirteen patients were classified as Child C cirrhosis. Thirty-six months actuarial survival is 60%. These results are similar in patients selected for surgical resection.